Kaushal Neil, Chen Cynthia, Agarwal Kunal N, Schrader Tim, Kelly Derek, Dodwell Emily R
Rutgers-New Jersey Medical School, Newark, NJ.
New York Presbyterian, Columbia University Irving Medical Center.
J Pediatr Orthop. 2019 Jul;39(6):e406-e411. doi: 10.1097/BPO.0000000000001359.
Unstable slipped capital femoral epiphysis (SCFE) may lead to avascular necrosis (AVN) in up to 60% of patients. The aim of this study was to assess the best clinical evidence to determine the effect of capsular decompression (CD) on odds of AVN in unstable SCFE.
Medline, Embase, and Cochrane databases were systematically searched for comparative studies investigating AVN rates in unstable SCFE treated with or without CD (aspiration, percutaneous, or open). Quality was evaluated by the Newcastle Ottawa Scale. A comparative analysis with pooled effect estimates using random-effects modeling was calculated. Secondary analysis pooled AVN rates from both comparative studies and case series.
Comparative analysis included 17 retrospective studies with 453 hips (201 with CD, 252 without CD). Thirty-four of 201 (17%) hips with CD developed AVN, while 67 of 252 (27%) hips without CD developed AVN. The odds of AVN for patients treated with or without CD [odds ratio=0.80, 95% confidence interval (CI): 0.48-1.35] was not statistically different. Subanalysis on patients treated with in situ pinning or positional reduction and pinning showed no difference in AVN rates with or without CD (odds ratio=0.97, 95% CI: 0.44-2.10). In the secondary analysis of 17 comparative studies and 23 case series, the average rate of AVN was 17%, 0.17 (95% CI: 0.13-0.23) for patients treated with CD (60/447 hips) and 28%, 0.28 (95% CI: 0.22-0.35) for patients treated without CD (129/464 hips).
There was no statistically significant decrease in odds of AVN with CD. However, studies were limited by their retrospective nature and inadequate documentation of CD techniques; the majority lacked femoral head blood flow monitoring to demonstrate adequate decompression. Future prospective studies with carefully documented complete decompression may help to elucidate the effect of CD on AVN risk. Although there was no statistically different odds of AVN with or without CD, even this large meta-analysis was underpowered, and one cannot conclude that there was truly no difference in odds of AVN without an appropriately powered study. Therefore, we recommend routine CD for all unstable SCFEs pending additional research, as CD adds little to the surgical procedure and may minimize the risk of a devastating insult to the femoral head.
不稳定型股骨头骨骺滑脱(SCFE)患者中,高达60%可能会发生股骨头缺血性坏死(AVN)。本研究的目的是评估最佳临床证据,以确定关节囊减压(CD)对不稳定型SCFE患者发生AVN几率的影响。
系统检索Medline、Embase和Cochrane数据库,查找比较研究,这些研究调查了接受或未接受CD(穿刺抽吸、经皮或开放手术)治疗的不稳定型SCFE患者的AVN发生率。采用纽卡斯尔渥太华量表评估质量。使用随机效应模型计算合并效应估计值的比较分析。二级分析汇总了比较研究和病例系列中的AVN发生率。
比较分析纳入了17项回顾性研究,共453例髋关节(201例接受CD治疗,252例未接受CD治疗)。接受CD治疗的201例髋关节中有34例(17%)发生AVN,而未接受CD治疗的252例髋关节中有67例(27%)发生AVN。接受或未接受CD治疗的患者发生AVN的几率[优势比=0.80,95%置信区间(CI):0.48 - 1.35]无统计学差异。对采用原位穿针或复位固定治疗的患者进行亚组分析显示,接受或未接受CD治疗的患者AVN发生率无差异(优势比=0.97,95% CI:0.44 - 2.10)。在对17项比较研究和23个病例系列的二级分析中,接受CD治疗的患者(60/447例髋关节)AVN平均发生率为17%,0.17(95% CI:0.13 - 0.23),未接受CD治疗的患者(129/464例髋关节)为28%,0.28(95% CI:0.22 - 0.35)。
CD治疗并未使AVN几率出现统计学上的显著降低。然而,这些研究受限于回顾性性质以及CD技术记录不充分;大多数研究缺乏股骨头血流监测以证明减压充分。未来进行仔细记录完全减压情况的前瞻性研究可能有助于阐明CD对AVN风险的影响。尽管接受或未接受CD治疗的患者发生AVN的几率在统计学上无差异,但即使是这项大型荟萃分析的效能也不足,在没有进行适当效能研究的情况下,不能得出AVN几率确实没有差异的结论。因此,在有更多研究之前,我们建议对所有不稳定型SCFE患者常规进行CD治疗,因为CD对手术操作影响不大,且可能将股骨头遭受严重损伤的风险降至最低。